{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:20:11Z","timestamp":1746591611900,"version":"3.40.5"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>In-stent restenosis (ISR) is the Achilles\u2019 heel of percutaneous coronary intervention (PCI). There have been controversial data about outcomes of repeated PCI (redo-PCI) for ISR. This study aims to determine the predictors of major adverse cardiac events (MACE) in patients underwent redo-PCI for ISR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this retrospective study, all patients with acute coronary syndrome who were underwent successful PCI for ISR at Tehran Herat Center (between 2004 and 2019) were eligible for inclusion. Patients with moderate to severe valvular heart disease and\/or hematological disorders were excluded. Participants were divided into 2 groups based on the occurrence of the MACE [composite of cardiovascular death, myocardial infarction (MI), coronary artery bypass grafting, target vessel revascularization, and target lesion revascularization]; then, the study variables were compared between the 2 groups. Finally, the predictors of MACE were identified using Cox regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 748 redo-PCI patients (mean age: 65.2\u2009\u00b1\u200910.1; 71.0% males), 631 patients had met the inclusion criteria. Fifty-four patients (9.8%) developed MACE within a 1-year follow-up period. Multivessel disease, primary PCI, Ad-hoc PCI, history of non\u2013ST-segment elevation MI, and diabetes mellitus were independent predictors for MACE. In a subgroup analysis, 30 patients who experienced third PCI (target lesion revascularization\/target vessel revascularization) were followed more as 1-year MACE. Among these patients, 14 MACEs were observed during the last follow-up (till June 2020).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Multivessel disease, primary PCI, and history of non\u2013ST-segment elevation MI were the predictors of higher 1-year MACE, whereas Ad-hoc PCI and diabetes mellitus had a protective effect on MACE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000283","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T15:00:10Z","timestamp":1649862010000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["In-hospital and 1-Year Outcomes of Repeated Percutaneous Coronary Intervention for In-stent Restenosis With Acute Coronary Syndrome Presentation"],"prefix":"10.1097","volume":"21","author":[{"given":"Younes","family":"Nozari","sequence":"first","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed","family":"Mojtaba Ghorashi","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Alidoust","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh","family":"Hamideh Mortazavi","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Jalali","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Omidi","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Fazeli","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Aghajani","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Salarifar","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Reza Amirzadegan","sequence":"additional","affiliation":[{"name":"From the Department of Cardiovascular Disease Research, Tehran Heart Center (THC), Tehran University of Medical Sciences, Tehran, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4068\/cmj.2017.53.3.203","article-title":"Identification of risk factors influencing in-stent restenosis with acute coronary syndrome presentation.","volume":"53","author":"Cho","year":"2017","journal-title":"Chonnam Med J"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era.","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250506","first-page":"375","article-title":"Clinical coronary in-stent restenosis follow-up after treatment and analyses of clinical outcomes.","volume":"104","author":"Marino","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heart.84.3.307","article-title":"Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries.","volume":"84","author":"Gross","year":"2000","journal-title":"Heart"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0002-9149(00)00789-X","article-title":"Predictors of clinical outcome following percutaneous intervention for in-stent restenosis.","volume":"85","author":"Klugherz","year":"2000","journal-title":"Am J Cardiol"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ehbc.2004.11.030","article-title":"Drug-eluting stents reduce restenosis rates and major adverse cardiac events, but not mortality, in patients undergoing percutaneous coronary intervention.","volume":"9","author":"Kong","year":"2005","journal-title":"Evid Based Healthc Public Health"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s43044-019-0025-z","article-title":"In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario.","volume":"71","author":"Paramasivam","year":"2019","journal-title":"Egypt Heart J"},{"key":"R9-20250506","first-page":"28","article-title":"In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: clinical presentation, angiographic features, and outcomes.","volume":"23","author":"Paramasivam","year":"2020","journal-title":"Anatol J Cardiol"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents.","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ccd.26559","article-title":"Resistant in-stent restenosis in the drug eluting stent era.","volume":"88","author":"Theodoropoulos","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis.","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(03)00852-0","article-title":"A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.","volume":"42","author":"Alfonso","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD).","volume":"41","author":"Cosentino","year":"2019","journal-title":"Eur Heart J"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH).","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"R21-20250506","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","author":"Levey","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ccd.24701","article-title":"Ad hoc percutaneous coronary intervention: a consensus statement from the Society for Cardiovascular Angiography and Interventions.","volume":"81","author":"Blankenship","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.acvd.2009.01.004","article-title":"Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.","volume":"102","author":"De Labriolle","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2006.04.007","article-title":"Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).","volume":"98","author":"Assali","year":"2006","journal-title":"Am J Cardiol"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4244\/EIJV5I7A141","article-title":"A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.","volume":"5","author":"Rathore","year":"2010","journal-title":"EuroIntervention"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00392-019-01550-7","article-title":"A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.","volume":"109","author":"Lee","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ahj.2015.06.005","article-title":"Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.","volume":"170","author":"Kim","year":"2015","journal-title":"Am Heart J"},{"key":"R29-20250506","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12933-018-0793-x","article-title":"Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.","volume":"17","author":"Zhou","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12872-016-0445-6","article-title":"Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.","volume":"17","author":"Zhao","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"article-title":"Clinical outcomes after percutaneous coronary intervention in patients with and without history of diabetes mellitus with different stent size. Research Square.","year":"2020","author":"Zibaeenezhad","key":"R31-20250506"},{"key":"R32-20250506","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00392-012-0414-8","article-title":"Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials.","volume":"101","author":"de Waha","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"R33-20250506","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2016.12.176","article-title":"Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.","volume":"230","author":"Lee","year":"2017","journal-title":"Int J Cardiol"},{"key":"R34-20250506","first-page":"146","article-title":"A long-term single-center registry of 6893 patients undergoing elective percutaneous coronary intervention with the xience everolimus-eluting stent.","volume":"31","author":"Trabattoni","year":"2019","journal-title":"J Invasive Cardiol"},{"key":"R35-20250506","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","article-title":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.","volume":"28","author":"Sorajja","year":"2007","journal-title":"Eur Heart J"},{"key":"R36-20250506","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcin.2009.01.006","article-title":"Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions.","volume":"2","author":"Hannan","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R37-20250506","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjcard.2006.09.093","article-title":"Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry).","volume":"99","author":"Feldman","year":"2007","journal-title":"Am J Cardiol"},{"key":"R38-20250506","first-page":"194","article-title":"Feasibility and safety of ad hoc percutaneous coronary intervention in the modern era.","volume":"21","author":"Good","year":"2009","journal-title":"J Invasive Cardiol"},{"key":"R39-20250506","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cjco.2019.05.003","article-title":"Total and cause-specific mortality after percutaneous coronary intervention: observations from the alberta provincial project for outcome assessment in coronary heart disease registry.","volume":"1","author":"Tran","year":"2019","journal-title":"CJC Open"},{"key":"R40-20250506","first-page":"313","article-title":"Clinical outcomes of rotational atherectomy in severely calcified in-stent restenosis: a single-center, retrospective study.","volume":"81","author":"Uemura","year":"2019","journal-title":"Nagoya J Med Sci"},{"key":"R41-20250506","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.amjcard.2019.11.035","article-title":"Combined vascular brachytherapy and stenting for the treatment of in-stent restenosis.","volume":"125","author":"Chen","year":"2020","journal-title":"Am J Cardiol"},{"key":"R42-20250506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1536\/ihj.17-693","article-title":"Clinical outcomes after treatment with ELCA for in-stent restenosis of DES.","volume":"59","author":"Nakamura","year":"2018","journal-title":"Int Heart J"},{"key":"R43-20250506","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1002\/ccd.28983","article-title":"Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: a single-center, retrospective study.","volume":"97","author":"Yasumura","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"R44-20250506","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:03:00Z","timestamp":1746558180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000283","relation":{},"ISSN":["1535-2811"],"issn-type":[{"type":"electronic","value":"1535-2811"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}